Long-Term Oncologic Outcomes, Opioid Use, and Complications after Esophageal Cancer Surgery
Open accessThe DOI matches its Crossref record; 22 of the 24 references it cites were found in a registry or an index.
Abstract
Effective and adequate opioid use and prevention of postoperative complications are important for enhanced recovery after surgery. We examined the effects of postoperative opioid use and postoperative complications on overall survival and recurrence-free survival after esophageal cancer surgery. This retrospective cohort study analyzed the records of patients diagnosed with esophageal cancer who underwent the Ivor Lewis operation between January 2005 and December 2011. We collected data on total opioid use for 8 days postoperatively, as well as information on postoperative complications (Clavien-Dindo classification). One hundred and twenty-one patients were included in the final analysis. Total opioid use was not significantly associated with overall survival (p = 0.520) and recurrence-free survival (p = 0.818). In contrast, the hazard ratio of postoperative overall survival was significantly higher with respect to Clavien-Dindo classification 1–2 (hazard ratio: 2.009, p = 0.046), 3a–3b (hazard ratio: 5.759, p < 0.001), and 4a–5 (hazard ratio: 3.982, p = 0.020) complications compared to no complications. Additionally, the hazard ratio of the recurrence-free survival was significantly higher in class 1–2 complications (hazard ratio: 2.336, p = 0.028) compared to none. Our study demonstrates that postoperative opioid use is not associated with survival and recurrence-free survival after esophageal cancer surgery, while postoperative complications may increase the hazard ratio for survival and recurrence-free survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, squamous carcinoma is the most common pathogenic form of esophageal cancer in China [18].Its growth rate and pathological changes are diferent from those of adenocarcinoma [19], so the patient may experience diverse symptoms and thus interpret them variously.”
From Symptom Experiences before Medical Help-Seeking and Psychosocial Responses of Patients with Esophageal Cancer: A Qualitative Study. (2023) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience
Clavien, P. A., Barkun, J., de Oliveira, M. L., Vauthey, J. N., Dindo, D., Schulick, R. D., de Santibañes, E., Pekolj, J., Slankamenac, K., Bassi, C., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b13ca2 · Cited by 11,482 · cited 1×
“Postoperative complications were classified according to severity via the Clavien-Dindo classification (7 grades: 1, 2, 3a, 3b, 4a, 4b, and 5) [10].”
MethodEnzinger, P. C., & Mayer, R. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035010 · Cited by 2,509
Epidemiology of esophageal cancer
Zhang, Y. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i34.5598 · Cited by 984
Immune Dysfunction as a Cause and Consequence of Malnutrition
Bourke, C. D., Berkley, J. A., & Prendergast, A. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.04.003 · Cited by 725 · cited 1×
“Further, immune dysfunction caused by malnutrition as a result of various postoperative complications [19] may also be a contributing factor.”
BackgroundMarkar, S., Gronnier, C., Duhamel, A., Mabrut, J.-Y., Bail, J.-P., Carrere, N., Lefevre, J. H., Brigand, C., Vaillant, J.-C., Adham, M., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000001011 · Cited by 320 · cited 3×
“Postoperative complications using this classification were found to have an impact on patient OS or RFS in two previous studies [7,8], and our findings support the findings of these studies.”
BackgroundResultLerut, T., Moons, J., Coosemans, W., Van Raemdonck, D., De Leyn, P., Decaluwé, H., Decker, G., & Nafteux, P. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181bdd5a8 · Cited by 272 · cited 3×
“Postoperative complications using this classification were found to have an impact on patient OS or RFS in two previous studies [7,8], and our findings support the findings of these studies.”
BackgroundResultThe Effects of Postoperative Pain Management on Immune Response to Surgery
Beilin, B., Shavit, Y., Trabekin, E., Mordashev, B., Mayburd, E., Zeidel, A., & Bessler, A. H. (2003) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000078586.82810.3b · Cited by 251 · cited 1×
“First, postoperative complications may induce immunosuppressive effects via the stress response to more severe postoperative pain [18] and through immunosuppression caused by increased opioid use [6].”
BackgroundEsophageal cancer: Clinical Practice Guidelines for diagnosis, treatment and follow-up
Stahl, M., Budach, W., Meyer, H., & Cervantes, A. M. R. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq163 · Cited by 138
Cata, J. P., Keerty, V., Keerty, D., Feng, L., Norman, P. H., Gottumukkala, V. N. R., Mehran, J., & Engle, M. (2014) · Cancer Medicine · doi:10.1002/cam4.236 · Cited by 136 · cited 2×
“These findings are in contrast with those of previous studies that suggested an association between opioid use and cancer recurrence [13,14].”
BackgroundResultMaher, D. P., Wong, W., White, P. F., McKenna, R., Rosner, H. L., Shamloo, B., Louy, C., Wender, R. H., Yumul, R., & Zhang, V. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu192 · Cited by 104 · cited 1×
“These findings are in contrast with those of previous studies that suggested an association between opioid use and cancer recurrence [13,14].”
ResultInitial Experiences of an Enhanced Recovery Protocol in Esophageal Surgery
Blom, R. L. G. M., van Heijl, M., Bemelman, W. A., Hollmann, M. W., Klinkenbijl, J. H. G., Busch, O. R., & Henegouwen, M. I. V. B. (2013) · World Journal of Surgery · doi:10.1007/s00268-013-2135-1 · Cited by 91 · cited 1×
“Enhanced recovery after surgery (ERAS), an important care pathway to effectively facilitate early recovery in postoperative patients, has short-term benefits including reduced hospital stay after esophageal cancer surgery [5].”
BackgroundDoes regional analgesia reduce the risk of cancer recurrence? A hypothesis
Sessler, D. I. (2008) · European Journal of Cancer Prevention · doi:10.1097/cej.0b013e3282f0c005 · Cited by 88 · cited 1×
“The postoperative period is known to be an important period for recurrence and metastasis after curative surgery [15], and postoperative opioid use, which has protumoral and immunosuppressive effects, is an important issue in oncology [6,13].”
BackgroundZhang, Y., Xu, Q., Liao, L.-D., Xu, X., Wu, J., Wu, Z.-Y., Shen, J., Li, E.-M., & Xu, L. (2014) · Diseases of the Esophagus · doi:10.1111/dote.12165 · Cited by 61 · cited 1×
“Moreover, recent studies have suggested that many esophageal squamous cell carcinoma cells express mu-opioid receptors, which may promote tumor cell growth and facilitate metastasis [16] This has raised concerns that opioid use in the postoperative period after esophageal cancer surgery may have adverse effects on lon…”
BackgroundHow regional analgesia might reduce postoperative cancer recurrence
Cata, J. P., Gottumukkala, V. N. R., & Sessler, D. I. (2011) · European Journal of Pain Supplements · doi:10.1016/j.eujps.2011.08.017 · Cited by 52 · cited 3×
“First, postoperative complications may induce immunosuppressive effects via the stress response to more severe postoperative pain [18] and through immunosuppression caused by increased opioid use [6].”
BackgroundRaj's practical management of pain
Benzon, H. T., & Raj, P. P. (n.d.) · Cited by 48
Future Perspectives of ERAS: A Narrative Review on the New Applications of an Established Approach
Bugada, D., Bellini, V., Fanelli, A., Marchesini, M., Compagnone, C., Baciarello, M., Allegri, M., & Fanelli, G. C. (2016) · Surgery Research and Practice · doi:10.1155/2016/3561249 · Cited by 32 · cited 1×
“benefits of ERAS, these two factors are also important with regard to long-term outcomes, particularly oncologic outcomes, which have recently emerged as a topic of emphasis [9].”
BackgroundInconsistencies in Opioid Equianalgesic Ratios: Clinical and Research Implications
O’Bryant, C. L., Linnebur, S. A., Yamashita, T. E., & Kutner, J. S. (2008) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360280802537241 · Cited by 27 · cited 1×
“Third, we used an opioid conversion ratio, but the accuracy of this conversion ratio remains controversial [22].”
MethodImpact of lymph‐node metastasis site in patients with thoracic esophageal cancer
Kunisaki, C., Makino, H., Kimura, J., Oshima, T., Fujii, S., Takagawa, R., Kosaka, T., Ono, H. A., & Akiyama, H. (2009) · Journal of Surgical Oncology · doi:10.1002/jso.21425 · Cited by 27 · cited 1×
“Although patients with 2+ and 3+ lymph node status were excluded from the study because of a large tumor burden, our findings are unusual considering that lymph node status has been associated with recurrence after esophageal cancer surgery [20].”
BackgroundWorni, M., Castleberry, A. W., Gloor, B., Pietrobon, R. S., Haney, J. C., D’Amico, T. A., Akushevich, I. V., & Berry, M. F. (2013) · Diseases of the Esophagus · doi:10.1111/dote.12123 · Cited by 26
Chen, H., Wang, Z., Yang, Z., Shang, B., Liu, X., & Chen, G. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-2928-3 · Cited by 20 · cited 1×
“In general, adjuvant radiotherapy is performed for patients with a more advanced tumor stage or patients whose resection margin is narrower, even if complete resection was performed [21].”
BackgroundUmezawa, H., Nakao, J., Matsutani, T., Kuwahara, H., Taga, M., & Ogawa, R. (2016) · Plastic & Reconstructive Surgery Global Open · doi:10.1097/gox.0000000000001113 · Cited by 13 · cited 1×
“Recent studies have reported that the Clavien-Dindo classification provides an effective assessment of complications after esophageal cancer surgery [17].”
(1994) · PubMed · Cited by 8
Research works printed but not linked: 1
- Jacox, 1994, Management of cancer pain-adults, Am. Fam. Physician, 49, 1853
Cited by
He, Y., Liang, D., Du, L., Guo, T., Liu, Y., Sun, X., Wang, N., Zhang, M., Wei, K., Shan, B., et al. (2020) · 癌症:英文版 · doi:10.1002/cac2.12087 · Cited by 120
“F IGURE 1 Distribution of the participating hospitals comprising of provincial (blue color), and municipal and county (orange color) hospitals Therefore, the aim of this study was to use a large number of multicenter cases to determine the lifestyle and clinical risk factors related to the survival of EC patients in C…”
BackgroundInfluentialOh, T. K., Kim, K., Jheon, S., Lee, J., Do, S.-H., Hwang, J., & Song, I. (2018) · Cancer Control · doi:10.1177/1073274818775360 · Cited by 94
“However, we reported recently that remifentanil dosage during surgery was not clinically associated with OS or RFS in esophageal cancer surgery.(18) In summary, issues regarding the impact of epidural analgesia or opioid use on OS or RFS in lung cancer are still questionable.”
BackgroundSelf-citationAnesthetic Approaches and Their Impact on Cancer Recurrence and Metastasis: A Comprehensive Review
Choi, H., & Hwang, W. (2024) · Cancers · doi:10.3390/cancers16244269 · Cited by 57
Zheng, J., He, J., Wang, W., Zhou, H., Cai, S., Zhu, L., Qian, X., Wang, J., Lu, Z., & Huang, C. (2020) · Medicine · doi:10.1097/md.0000000000019306 · Cited by 45
Díaz‐Cambronero, Ó., Mazzinari, G., Giner, F., Belltall, A., Ruiz-Boluda, L., Marí, A. M., Sánchez‐Guillén, L., Eroles, P., Cata, J. P., & Argente-Navarro, M. P. (2020) · Cancers · doi:10.3390/cancers12010134 · Cited by 27
“While it decreased survival on early stages of lung cancer [38] had no impact on colorectal or esophageal cancers [30,39,40].”
Background
Metadata
- Authors
- Oh, T. K., Kim, K., Jheon, S. H., Do, S.-H., Hwang, J.-W., Jeon, Y.-T., Kim, K., & Song, I.-A.
- Affiliations
- Seoul National University (KR)
- Seoul National University Bundang Hospital (KR)
- Corresponding author
- Song, In-Ae
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2018-02-19
- Volume
- 7
- Issue
- 2
- Pages
- 33
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC5852449
- OpenAlex
- W2792539867
- Cited by
- 20
- References
- 24
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 3 · 2021: 2 · 2020: 5 · 2018: 1
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Health Sciences › Medicine › Surgery › Enhanced Recovery After Surgery
- Keywords
- esophageal cancer, postoperative opioid use, postoperative complications, Clavien-Dindo classification, overall survival, recurrence-free survival, enhanced recovery after surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.